osaühing VÄRSKA VARARegistered
Key figures
1 185 925 €−3,2%
Revenue 2025
+4,6%
Average annual growth 2019–2025
Ratios
20252,1%
Profit margin
26,7%
EBITDA margin
22,8%
Equity ratio
0,5×
Current ratio
3,1%
Return on equity
906 €
Average gross salary
Balance sheet structure
Current assetsNon-current assetsLiabilitiesEquity
Quarterly figures
| Quarter | Revenue | Number of employees | Labour taxes |
|---|---|---|---|
| Q2 2026 | 274 896 € | 20 | 24 465 € |
| Q1 2026 | 239 364 € | 20 | 29 997 € |
| Q4 2025 | 295 854 € | 20 | 29 438 € |
| Q3 2025 | 322 393 € | 23 | 31 014 € |
| Q2 2025 | 285 495 € | 22 | 28 117 € |
| Q1 2025 | 281 621 € | 21 | 29 923 € |
Source: Tax Board open data — based on VAT returns, may not exactly match revenue in the annual report. Updated quarterly.
Summary of financial statements2019–2025
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|
| Balance sheet — assets | |||||||
| Total current assets | 96 616 | 29 965 | 58 562 | 42 053 | 30 061 | 47 678 | 138 983 |
| Total non-current assets | 2 632 226 | 3 935 874 | 3 805 940 | 3 650 810 | 3 575 874 | 3 482 597 | 3 369 010 |
| Total assets | 2 728 842 | 3 965 839 | 3 864 502 | 3 692 863 | 3 605 935 | 3 530 275 | 3 507 993 |
| Balance sheet — liabilities and equity | |||||||
| Current liabilities | 1 126 743 | 293 752 | 197 637 | 255 684 | 260 464 | 2 755 349 | 278 433 |
| Non-current liabilities | 602 903 | 2 772 185 | 2 772 181 | 2 615 181 | 2 574 135 | 0 | 2 430 013 |
| Total liabilities | 1 729 646 | 3 065 937 | 2 969 818 | 2 870 865 | 2 834 599 | 2 755 349 | 2 708 446 |
| Share capital | 25 565 | 25 565 | 25 565 | 25 565 | 25 565 | 25 565 | 25 565 |
| Retained earnings of previous periods | 466 364 | 499 161 | 399 867 | 394 649 | 321 963 | 271 301 | 274 891 |
| Profit for the year | 32 797 | −99 294 | −5218 | −72 686 | −50 662 | 3590 | 24 621 |
| Reserves and other equity | 474 470 | 474 470 | 474 470 | 474 470 | 474 470 | 474 470 | 474 470 |
| Total equity | 999 196 | 899 902 | 894 684 | 821 998 | 771 336 | 774 926 | 799 547 |
| Income statement | |||||||
| Sales revenue | 903 001 | 754 728 | 903 252 | 1 067 639 | 1 143 124 | 1 224 842 | 1 185 925 |
| Operating profit | 62 804 | −41 117 | 70 920 | 10 841 | 90 530 | 145 829 | 111 909 |
| EBITDA | 184 170 | 128 893 | 269 175 | 210 279 | 287 512 | 345 178 | 316 463 |
| Profit before income tax | 32 797 | −99 294 | −5218 | −72 686 | −50 662 | 3590 | 24 621 |
| Profit for the reporting year | 32 797 | −99 294 | −5218 | −72 686 | −50 662 | 3590 | 24 621 |
| Labour costs | 286 015 | 317 669 | 301 327 | 360 417 | 330 201 | 343 291 | 349 380 |
| Depreciation of non-current assets | 121 366 | 170 010 | 198 255 | 199 438 | 196 982 | 199 349 | 204 554 |
| Other indicators | |||||||
| Employees | 20 | 20 | 19 | 19 | 19 | 19 | 19 |
| Calculated dividend | — | 0 | 0 | 0 | 0 | 0 | 0 |
A dash (—) means the report has not been filed or the line is not reported; 0 is a zero stated in the report.
Connections graph
Click a node to see its other connections.
CompanyPersonShareholderOther roleAdditional link
Related companies
Same activity — Lepinguline toitlustusteenus jm toitlustamine
Same address